GPT Healthcare logo

GPT Healthcare financials: balance sheet, profit and loss, cash flow

NSE: GPTHEALTHBSE: 544131Healthcare ServicesSmall Cap

GPT Healthcare Limited · Face value ₹10 · Listed Feb 2024 · Issue price ₹186
Last close ₹134.48up ₹0.38 (0.28%)BSE ₹134.55

Share price at the NSE close on 28 Oct 2026. Previous close ₹134.10.

28 Oct: open ₹134.00, high ₹135.59, low ₹132.02

52-week range of traded prices to 28 Oct 2026
₹115.00Low, 27 Mar 2026₹175.00High, 31 Jul 2026
Market cap
₹1,103 Cr1,433rd largest listed
P/E
23.34
P/B
4.10
Dividend yield
1.86%
ROE
18.3%
ROCE
22.1%
Debt to equity
0.06
Volume, NSE
30,597

GPT Healthcare's financial statements for the 3 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

3 years at a glance

₹ crore, years to March.GPT Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
4004812Mar 244075013Mar 254734216Mar 26
Peak revenue ₹473 Cr, year to Mar 2026; lowest ₹400 Cr, year to Mar 2024

Operating and net margin, per cent

  • Operating margin
  • Net margin
21.9%8.9%21.9%20.5%17.8%11.9%12.3%8.9%Mar 24Mar 25Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue473
  2. Materials and goods−90
  3. Employee costs−84
  4. Other expenses−214
  5. Operating profit84
  6. Depreciation−27
  7. Other income+6.0
  8. One-off items0.0
  9. Finance costs−8.2
  10. Profit before tax55
  11. Tax−13
  12. Net profit42

What the company owns

  • Plant, investments and other assets₹386 Cr
  • Current investments₹43 Cr
  • Receivables₹20 Cr
  • Inventory₹11 Cr
  • Cash and bank₹4 Cr

What pays for it: net worth and liabilities

  • Net worth₹269 Cr
  • Other liabilities₹137 Cr
  • Owed to suppliers₹42 Cr
  • Borrowings₹16 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.GPT Healthcare quarterly results

₹ croreMar 2024Mar 2025Filed 23 MayMar 2026Filed 18 MayJun 2026Twelve monthsFiled 3 Aug
Revenue from operations400407473492
312324388401
Materials and goods bought83799093
Employee costs69738487
Other expenses160172214220
Operating profit before depreciation88838491
Operating margin21.9%20.5%17.8%18.5%
Materials, % of revenue20.7%19.4%19.0%19.0%
Employee costs, % of revenue17.2%17.9%17.9%17.7%
Other expenses, % of revenue40.1%42.2%45.3%44.8%
Depreciation and amortisation18192728
Operating profit after depreciation70645763
Other income5866
Finance costs7389
One-off items0000
Profit before tax68695561
20191314
Net profit48504247
Other comprehensive income0000
Total comprehensive income48504247
Net margin11.9%12.3%8.9%9.6%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2024Mar 2025Filed 23 MayMar 2026Filed 18 May
218248269
Share capital828282
Reserves136166187
121316
777479
5062116
Total assets346384465
265305375
807989
Net debt−8−23−31
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2024Mar 2025Filed 23 MayMar 2026Filed 18 May
68.867.481.2
83.884.594.2
−6.2−3.65.5
Receivables−5.4−0.1−3.5
Inventories0.8−0.7−1.8
Payables4.5−2.47.2
Other working capital−6.0−0.43.5
Tax paid−15.0−17.1−13.0
Capital spending19.449.941.8
Free cash flow49.417.539.3
−25.2−32.6−47.3
−48.5−34.8−31.4
Dividends paid24.028.720.5
Shares bought back2.50.00.0
Shares issued40.00.00.0
Net change in cash−4.90.02.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.GPT Healthcare dividend history

₹ per shareMar 2024Mar 2025Filed 23 MayMar 2026Filed 18 May
Earnings per share₹5.96₹6.08₹5.15
Diluted earnings per share₹5.96₹6.08₹5.15
Dividend per share₹2.50₹2.50₹2.50
Book value per share₹26.63₹30.21₹32.84
Dividend payout42.9%41.1%48.6%
Shareholder yield−0.9%2.4%2.2%
Market cap at the year end (₹ crore)1,4471,206946

Ratios

Standalone, years to March.GPT Healthcare PE ratio and valuation

RatioMar 2024Mar 2025Filed 23 MayMar 2026Filed 18 May
Revenue growth–1.7%16.1%
Operating profit growth–−5.1%1.0%
Net profit growth–4.5%−15.4%
Earnings per share growth–2.0%−15.3%
21.9%21.4%16.3%
–−0.5 pts−5.1 pts
From the net margin–0.6 pts−5.8 pts
From asset turnover–−0.8 pts0.0 pts
From borrowing–−0.2 pts0.8 pts
Return on capital employed30.3%24.6%20.0%
Cash conversion144.0%135.0%192.2%
Interest cover9.818.56.9
Debt to equity0.060.050.06
Receivable days222216
Inventory days364143
Payable days164161170
Cash conversion cycle, days−106−98−112
Working capital days−8−21−22
Asset turnover1.161.121.11
Assets per rupee of net worth1.581.561.64
Sales per rupee of plant1.992.011.78
Capital spending to depreciation1.082.621.54
Plant being built, % of plant in use3.2%22.9%0.3%

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
9.9%
Cash from operations against operating profit
96.4%
Measure3 years
Return on equity, average19.9%
Return on capital employed, average25.0%
Operating margin, average20.1%
Net margin, average11.0%
Asset turnover, average1.13
Cash conversion cycle, days, average−105
Interest cover, average11.8
Debt to equity, average0.06

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations21781
Cash from investing−105−47
Cash from financing−115−31
Capital spending11142
Dividends paid7321
Shares bought back20
Shares issued for cash400
Borrowings raised2414
Borrowings repaid7311

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––7
Altman Z-scorePublished threshold 1.819.277.614.96
Beneish M-scorePublished threshold −1.78–−2.23−3.04
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–4.141.96
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––1.55
Receivables growth less revenue growthOur threshold 0 percentage points–0.86−34.66
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–13.246.17
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−1.850.24
Assets under construction, years of additionsOur threshold 2 years of additions–2.260.01
Effective tax ratePublished threshold 17.16 per cent29.8028.0122.96
Tax charged less tax paid, % of profitOur threshold 10 percentage points7.723.38−0.81
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
27 Oct 2025CRISIL Ratings LimitedBank FacilitiesCrisil A2+Review, Re-affirm1
27 Oct 2025CRISIL Ratings LimitedBank FacilitiesCrisil A-Review, Re-affirmStable5
27 Oct 2025CRISIL Ratings LimitedBank FacilitiesWithdrawnReview, Other40.97
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.